Barnaby E. Clark, Ph.D.1,2*, Claire C. Shooter2*, Frances Smith1*, David Brawand1*, Laura Steedman1*, Matthew Oakley1*, Peter Rushton1*, Helen Rooks3*, Xunde Wang, PhD4*, Anthi Drousiotou5*, Andriani Kyrri6*, Xenia Felekis5*, Miranda Petrou5*, Andrew M Will, MD7*, Chris Fisher, Ph.D.8*, Douglas R. Higgs, FRS8, Cornelius Harteveld9*, Marion Phylipsen9*, Marina Kleanthous, PhD5* and Swee Lay Thein, MD, DSc2,10
1Department of Molecular Pathology, Viapath at King's College Hospital, London, United Kingdom
2Molecular Haematology, Division of Cancer Studies, King's College London, London, United Kingdom
3Molecular Haematology, King’s College London, London, United Kingdom
4Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD
5The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
6Thalassaemia Center, Nicosia, Cyprus
7Paediatric Haematology, Royal Manchester Children’s Hospital, Manchester, United Kingdom
8MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom
9Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands
10National Heart, Lung and Blood Institute, Sickle Cell Branch, National Institutes of Health, Bethesda, MD